Angiotensin converting enzyme (ACE) inhibitory peptides: Production and implementation of functional food

Current Pharmaceutical Design

Volumn 15, Issue 31, 2009, Pages 3622-3643

  De Leo, F ^a   Panarese, S ^b   Gallerani, R ^a,b   Ceci, L R ^a  

^a CNR   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Angiotensin converting enzyme inhibitory peptides; Biologically active peptides; Functional food

Indexed keywords

CAPTOPRIL; CASEIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA FRAGMENT;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANGIONEUROTIC EDEMA; BLOOD PRESSURE REGULATION; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COUGHING; DAIRY PRODUCT; DIZZINESS; DRUG ACTIVITY; DRUG INDUCED HEADACHE; DRUG SYNTHESIS; EGG; ENZYME INHIBITION; FATIGUE; FERMENTATION; FISH; FOOD INTAKE; FOOD PEPTIDOMICS; FOOD SAFETY; HEALTH; HEART PROTECTION; HUMAN; HYDROLYSIS; HYDROPHILICITY; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; IC 50; IN VITRO STUDY; IN VIVO STUDY; KIDNEY DISEASE; KIDNEY INJURY; LAW; MEAT; MOLECULAR WEIGHT; MORBIDITY; MORTALITY; NAUSEA; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEINURIA; RENAL PROTECTION; REVIEW; RISK REDUCTION; SIDE EFFECT; STRUCTURE ACTIVITY RELATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIETARY PROTEINS; FOOD; HUMANS; PEPTIDES; PROTEIN PRECURSORS;

EID: 70449556123     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209789271834     Document Type: Review

References (231)

1. Moller NP, Scholz-Ahrens KE, Roos N, Schrezenmeir J. Bioactive peptides and proteins from foods: indication for health effects. Eur J Nutr 2008; 47: 171-182
2. Vermeirssen V, Van Camp J, Verstraete W. Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br J Nutr 2004; 92: 357-366 (Pubitemid 40277058)
3. Hartmann R, Meisel H. Food-derived peptides with biological activity: from research to food applications. Curr Opin Biotechnol 2007; 18: 163-169 (Pubitemid 46575225)
4. Yamamoto N. Antihypertensive peptides derived from food proteins. Biopolymers 1997; 43: 129-134 (Pubitemid 27291391)
5. Meisel H. Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers 1997; 43: 119-128 (Pubitemid 27291390)
6. FitzGerald RJ, Murray BA, Walsh DJ. Hypotensive peptides from milk proteins. J Nutr 2004; 134: 980S-8.
7. Vercruysse L, Van Camp J, Smagghe G. ACE inhibitory peptides derived from enzymatic hydrolysates of animal muscle protein: a review. J Agric Food Chem 2005; 53: 8106-8115
8. Kitts DD, Weiler K. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr Pharm Des 2003; 9: 1309-1323
9. Kovacs-Nolan J, Phillips M, Mine Y. Advances in the value of eggs and egg components for human health. J Agric Food Chem 2005; 53: 8421-8431
10. Teschemacher H, Koch G, Brantl V. Milk protein-derived opioid receptor ligands. Biopolymers 1997; 43: 99-117. (Pubitemid 27291389)
11. Fiat AM, Migliore-Samour D, Jolles P, Drouet L, Bal dit Sollier C, Caen J. Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities. J Dairy Sci 1993; 76: 301-310
12. Korhonen H, Pihlanto A. Food-derived bioactive peptides - opportunities for designing future foods. Curr Pharm Des 2003; 9: 1297-1308 (Pubitemid 36592138)
13. Meisel H. Multifunctional peptides encrypted in milk proteins. Biofactors 2004; 21: 55-61. (Pubitemid 40921826)
14. Meisel H, FitzGerald RJ. Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharm Des 2003; 9: 1289-1295 (Pubitemid 36592137)
15. Migliore-Samour D, Jolles P. Casein, a prohormone with an immunomodulating role for the newborn? Experientia 1988; 44: 188-193
16. Meisel H. Overview on milk protein-derived peptides. Int Dairy J 1998; 8: 363-373
17. Pihlanto A, Akkanen S, Korhonen HJ. ACE-inhibitory and antioxidant properties of potato (Solanum tuberosum). Food Chem 2008; 109: 104-112
18. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117-1124
19. Pfeuffer M, Schrezenmeir J. Bioactive substances in milk with properties decreasing risk of cardiovascular diseases. Br J Nutr 2000; 84: S155-9. (Pubitemid 32106841)
20. Severin S, Wenshui X. Milk biologically active components as nutraceuticals: review. Crit Rev Food Sci Nutr 2005; 45: 645-656 (Pubitemid 43000474)
21. Erdmann K, Cheung BW, Schroder H. The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. J Nutr Biochem 2008; 19: 643-654
22. Miyoshi S, Ishikawa H, Kaneko T, Fukui F, Tanaka H, Maruyama S. Structures and activity of angiotensin-converting enzyme inhibitors in an alpha-zein hydrolysate. Agric Biol Chem 1991; 55: 1313-1318
23. Motoi H, Kodama T. Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides from wheat gliadin hydrolysate. Nahrung 2003; 47: 354-358 (Pubitemid 37378729)
24. Marczak ED, Usui H, Fujita H, Yang Y, Yokoo M, Lipkowski AW, et al. New antihypertensive peptides isolated from rapeseed. Peptides 2003; 24: 791-798 (Pubitemid 37020917)
25. Gouda KGM, Gowda LR, Rao AGA, Prakash V. Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). J Agric Food Chem 2006; 54: 4568-4573 (Pubitemid 44133701)
26. Ma M-S, In YB, Hyeon GL, Yang CB. Purification and identification of angiotensin I-converting enzyme inhibitory peptide from buckwheat (Fagopyrum esculentum Moench). Food Chem 2006; 96: 36-42.
27. Megias C, Pedroche J, Yust Mdel M, Alaiz M, Giron-Calle J, Millan M, et al. Affinity purification of angiotensin converting enzyme inhibitory peptides using immobilized ACE. J Agric Food Chem 2006; 54: 7120-7124 (Pubitemid 44554929)
28. Kamath V, Niketh S, Chandrashekar A, Rajini PS. Chymotryptic hydrolysates of kafirin, the storage protein of sorghum (Sorghum bicolor) exhibited angiotensin converting enzyme inhibitory activity. Food Chem 2007; 100: 306-311 (Pubitemid 43914193)
29. Sorensen R, Kildal E, Stepaniak L, Pripp AH, Sorhaug T. Screening for peptides from fish and cheese inhibitory to prolyl endopeptidase. Nahrung 2004; 48: 53-56 (Pubitemid 38368287)
30. Gomez-Ruiz JA, Ramos M, Recio I. Identification and formation of angiotensin-converting enzyme-inhibitory peptides in Manchego cheese by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 2004; 1054: 269-277 (Pubitemid 39445829)
31. Hernandez-Ledesma B, Ramos M, Recio I, Amigo L. Effect of beta-lactoglobulin hydrolysis with thermolysin under denaturing temperatures on the release of bioactive peptides. J Chromatogr A 2006; 1116: 31-37
32. Lopez-Exposito I, Minervini F, Amigo L, Recio I. Identification of antibacterial peptides from bovine kappa-casein. J Food Prot 2006; 69: 2992-2997 (Pubitemid 44954416)
33. Ferreira IMPLV, Eca R, Pinho O, Tavares P, Pereira A, Roque AC. Development and validation of an HPLC/UV method for quantification of bioactive peptides in fermented milks. J Liquid Chromatogr Related Technol 2007; 30: 2139-2147 (Pubitemid 47028537)
34. Wang W, Gonzalez De Mejia E. A new frontier in soy bioactive peptides that may prevent age-related chronic diseases. Comprehensive Rev Food Sci Food Safety 2005; 4: 63-78. (Pubitemid 44402009)
35. Megias C, Pedroche J, Yust MM, Giron-Calle J, Alaiz M, Millan F, et al. Affinity purification of copper-chelating peptides from sunflower protein hydrolysates. J Agric Food Chem 2007; 55: 6509-6514 (Pubitemid 47280023)
36. Megias C, Pedroche J, Yust M del Mar, Alaiz M, Giron-Calle J, Millan F, et al. Immobilization of angiotensin-converting enzyme on glyoxyl-agarose. J Agric Food Chem 2006; 54: 4641-4645
37. Pouliot Y, Gauthier SF, Groleau PE. Nutraceutical Proteins and Peptides in Health and Disease 2006; 639-658
38. Cushman, DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 1971; 20: 1637-1648
39. German JB, Schanbacher FL, Lonnerdal B, Medrano JF, McGuire MA, McManaman JL, et al. International milk genomics consortium. Trends in Food Sci Technol 2006; 17: 656-661
40. Lioe HN, Wada K, Aoki T, Yasuda M. Chemical and sensory characteristics of low molecular weight fractions obtained from three types of Japanese soy sauce (shoyu) - Koikuchi, tamari and shiro shoyu. Food Chem 2007; 100: 1669-1677 (Pubitemid 44142891)
41. FitzGerald RJ, O'Cuinn G. Enzymatic debittering of food protein hydrolysates. Biotechnol Adv 2006; 24: 234-237 (Pubitemid 43172055)
42. Ishibashi N, Ono I, Kato K, Shigenaga T, Shinoda I, Okai H, et al. Role of the hydrophobic amino acid residue in the bitterness of peptides. Agric Biol Chem 1988. 52: 91-94
43. Kilara A, Panyam D. Peptides from milk proteins and their properties. Crit Rev Food Sci Nutr 2003; 43: 607-633 (Pubitemid 38552292)
44. Minkiewicz P, Dziuba J, Iwaniak A, Dziuba M, Darewicz M. BIOPEP database and other programs for processing bioactive peptide sequences. J AOAC Int 2008; 91: 965-980
45. Dziuba J, Minkiewicz P. Influence of glycosylation on micelle-stabilizing ability and biological properties of C-terminal fragments of cow's-casein. Int Dairy J 1996; 6: 1017-1044 (Pubitemid 27295328)
46. Pripp AH. Initial proteolysis of milk proteins and its effect on formation of ACE-inhibitory peptides during gastrointestinal proteolysis: A bioinformatic, in silico, approach. Eur Food Res Technol 2005; 221: 712-716
47. Wu J, Aluko RE, Nakai S. Structural requirements of Angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides. J Agric Food Chem 2006; 54: 732-738 (Pubitemid 43274109)
48. Wu J, Aluko RE, Nakai S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship modeling of peptides containing 4-10 amino acid residues. QSAR Combinatorial Sci 2006; 25: 873-880 (Pubitemid 44621664)
49. Rutherfurd-Markwick KJ, Moughan PJ. Bioactive peptides derived from food. J AOAC Int 2005; 88: 955-966
50. Hayes M, Ross RP, Fitzgerald GF, Stanton C. Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part I: overview. Biotechnol J 2007; 2: 426-434 (Pubitemid 46736358)
51. Yamamoto N, Ejiri M, Mizuno S. Biogenic peptides and their potential use. Curr Pharm Des 2003; 9: 1345-1355 (Pubitemid 36592142)
52. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66: 365-378
53. Stanton C, Ross RP, Fitzgerald GF, Van Sinderen D. Fermented functional foods based on probiotics and their biogenic metabolites. Curr Opin Biotechnol 2005; 16: 198-203. (Pubitemid 40502961)
54. Gobbetti M, Smacchi E, Corsetti A. The proteolytic system of Lactobacillus sanfrancisco CB1: purification and characterization of a proteinase, a dipeptidase, and an aminopeptidase. Appl Environ Microbiol 1996; 62: 3220-3226 (Pubitemid 26304104)
55. Christensen JE, Dudley EG, Pederson JA, Steele JL. Peptidases and amino acid catabolism in lactic acid bacteria. Antonie Van Leeuwenhoek 1999; 76: 217-246 (Pubitemid 29440729)
56. Losacco M, Gallerani R, Gobbetti M, Minervini F, De Leo F. Production of active angiotensin-I converting enzyme inhibitory peptides derived from bovine beta-casein by recombinant DNA technologies. Biotechnol J 2007; 2: 1425-1434 (Pubitemid 350162264)
57. Junter GA, Jouenne T. Immobilized viable microbial cells: from the process to the proteome em leader or the cart before the horse. Biotechnol Adv 2004; 22: 633-658 (Pubitemid 39204624)
58. Lv GS, Huo GC, Fu XY. Expression of milk-derived antihypertensive peptide in Escherichia coli. J Dairy Sci 2003; 86: 1927-1931 (Pubitemid 39067052)
59. Oh SK, Park SY, Sung HC. Expression and purification of an ACE inhibitory peptide multimer from synthetic DNA in escherichia coli. J Microbiol Biotechnol 2002; 12: 59-64.
60. Shanahan F, Immunology. Therapeutic manipulation of gut flora. Science 2000; 289: 1311-1312
61. Renye JA, Jr, Somkuti GA. Cloning of milk-derived bioactive peptides in Streptococcus thermophilus. Biotechnol Lett 2008; 30: 723-730
62. Yang L, Wakasa Y, Takaiwa F. Biopharming to increase bioactive peptides in rice seed. J AOAC Int 2008; 91: 957-964
63. Yang L, Tada Y, Yamamoto MP, Zhao H, Yoshikawa M, Takaiwa F. A transgenic rice seed accumulating an anti-hypertensive peptide reduces the blood pressure of spontaneously hypertensive rats. FEBS Lett 2006; 580: 3315-3320 (Pubitemid 43729691)
64. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998; 4: 1241-1243
65. Expert WF, Ed. Consultation, Diet, nutrition and the prevention of chronic diseases. W.T.R. Series. GENEVA: WHO 2003; Vol.916.
66. Harris T, Cook EF, Kannel W, Schatzkin A, Goldman L. Blood pressure experience and risk of cardiovascular disease in the elderly. Hypertension 1985; 7: 118-124 (Pubitemid 15117149)
67. Kannel WB, Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens Suppl 1990; 8: S3-8.
68. Ondetti MA, Cushman DW. Enzymes of the renin-angiotensin system and their inhibitors. Annu Rev Biochem 1982; 51: 283-308.
69. Stevens BR, Fernandez A, Kneer C, Cerda JJ, Phillips MI, Woodward ER. Human intestinal brush border angiotensin-converting enzyme activity and its inhibition by antihypertensive Ramipril. Gastroenterology 1988; 94: 942-947 (Pubitemid 18103426)
70. Wyvratt MJ, Patchett AA. Recent developments in the design of angiotensin-converting enzyme inhibitors. Med Res Rev 1985; 5: 483-531 (Pubitemid 16087527)
71. Yang HY, Erdos EG, Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 1970; 214: 374-376
72. Erdos EG. Angiotensin I converting enzyme. Circ Res 1975; 36: 247-255
73. Millatt LJ, Abdel-Rahman EM, Siragy HM. Angiotensin II and nitric oxide: a question of balance. Regul Pept 1999; 81(1-3): 1-10.
74. Oliveri C, Ocaranza MP, Campos X, LavanderoS, Jalil JE. Angiotensin I-converting enzyme modulates neutral endopeptidase activity in the rat. Hypertension 2001; 38: 650-654
75. Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, Cameron-Smith D, et al. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci USA 2008; 105: 6531-6536 (Pubitemid 351754541)
76. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988; 62: 749-756 (Pubitemid 18103235)
77. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991; 68: 450-456
78. Weisinger HS, Begg DP, Egan GF, Jayasooriya AP, Lie F, Mathai ML, et al. Angiotensin converting enzyme inhibition from birth reduces body weight and body fat in Sprague-Dawley rats. Physiol Behav 2008; 93: 820-825
79. Eurich DT, Majumdar SR, Tsuyuki RT, Johnson JA. Reduced mortality associated with the use of ACE inhibitors in patients with type 2 diabetes. Diabetes Care 2004; 27: 1330-1334 (Pubitemid 38679979)
80. Solomon SD, Skali H, Bourgoun M, Fang J, Ghali JK, Martelet M, et al. Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study. Am Heart J 2005; 150: 257-262 (Pubitemid 41116250)
81. Rossi S. Australian Medicines Handbook 2003.
82. Okumura H, Nishimura E, Kariya S, Ohtani M, Uchino K, Fukatsu T, et al. [No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients]. Yakugaku Zasshi 2001; 121: 253-257 (Pubitemid 32230378)
83. Molinaro G, Cugno M, Perez M, Lepage Y, Gervais N, Agostoni A, et al. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of desarginine(9)-bradykinin. J Pharmacol Exp Ther 2002; 303: 232-237 (Pubitemid 35056473)
84. Luno J, Praga M, de Vinuesa SG. The reno-protective effect of the dual blockade of the renin angiotensin system (RAS). Curr Pharm Des 2005; 11: 1291-1300 (Pubitemid 40458274)
85. van de Wal RM, van Veldhuisen DJ, van Gilst WH, Voors AA. Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense? Eur Heart J 2005; 26: 2361-2367
86. Finnegan PM, Gleason BL. Combination ACE inhibitors and angiotensin II receptor blockers for hypertension. Ann Pharmacother 2003; 37: 886-889 (Pubitemid 36618378)
87. Krum H, Carson P, Farsang C, Maggioni AP, Glazer RD, Aknay N, et al. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT. Eur J Heart Fail 2004; 6: 937-945 (Pubitemid 39536310)
88. Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK, et al. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation 2005; 111: 3411-3419 (Pubitemid 40923394)
89. Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, et al. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy. Clin Nephrol 2005; 64: 35-40. (Pubitemid 40975063)
90. Whitman M. Understanding the perceived need for complementary and alternative nutraceuticals: lifestyle issues. Clin J Oncol Nurs 2001; 5: 190-194
91. Kalra EK. Nutraceutical - definition and introduction. AAPS PharmSci 2003; 5(3): E25.
92. Abbott RD, Curb JD, Rodriguez BL, Sharp DS, Burchfiel CM, Yano K. Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle-aged men. The Honolulu Heart Program. Stroke 1996; 27: 813-818
93. Yamamoto N, Takano T. Antihypertensive peptides derived from milk proteins. Nahrung 1999; 43: 159-164 (Pubitemid 129570442)
94. Seppo L, Jauhiainen T, Poussa T, Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 2003; 77: 326-330 (Pubitemid 36133373)
95. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996; 64: 767-771 (Pubitemid 26398281)
96. Cheung HS, Wang FL, Ondetti MA, Sabo EF, Cushman DW. Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence. J Biol Chem 1980. 255: 401-407
97. Suetsuna K. Isolation and characterization of angiotensin I converting enzyme inhibitor dipeptides derived from Allium sativum L (garlic). J Nutritional BioChem 1998; 9; 415-419 (Pubitemid 28561541)
98. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 1988; 85: 9386-9390 (Pubitemid 19027137)
99. Brew K. Structure of human ACE gives new insights into inhibitor binding and design. Trends Pharmacol Sci 2003; 24: 391-394 (Pubitemid 36952554)
100. Moskowitz DW. Is "somatic" angiotensin I-converting enzyme a mechanosensor? Diabetes Technol Therapeut 2002; 4: 841-858
101. Wang W, Shen S, Feng F, He G, Wang Z. Pharmacophore-based structure optimization of angiotensin converting enzyme inhibitory peptide. Sci China Ser B Chem 2008; 51(8: 786-793
102. Corradi HR, Chitapi I, Sewell BT, Georgiadis D, Dive V, Sturrock ED, et al. The structure of testis angiotensin-converting enzyme in complex with the C domain-specific inhibitor RXPA380. Biochemistry 2007; 46: 5473-5478 (Pubitemid 46717270)
103. Pina AS, Roque AC. Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme. J Mol Recognit 2008;
104. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 1995; 78: 777-783
105. Holmquist B, Bunning P, Riordan JF. A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem 1979; 95: 540-548 (Pubitemid 9194370)
106. Vermeirssen V, J. Van Camp, Verstraete W. Optimisation and validation of an angiotensin-converting enzyme inhibition assay for the screening of bioactive peptides. J Biochem Biophys Methods 2002; 51: 75-87. (Pubitemid 34203814)
107. Elbl G. and Wagner H. A new method for the in vitro screening of inhibitors of angiotensin-converting enzyme (ACE), using the chromophore- and fluorophore-labelled substrate, dansyltriglycine. Planta Med 1991; 57: 137-141
108. Meisel H. Biochemical properties of peptides encrypted in bovine milk proteins. Curr Med Chem 2005; 12: 1905-1919 (Pubitemid 41015186)
109. Meisel HWD, Murray BA, FitzGerald RJ. In: Francis T, Ed. Nutraceutical proteins and peptides in health and disease: factors on the body's regulation system. New York. 2006: pp. 269-315.
110. Murakami M, Tonouchi H, Takahashi R, Kitazawa H, Kawai Y, Negishi H, et al. Structural analysis of a new anti-hypertensive peptide (beta-lactosin B) isolated from a commercial whey product. J Dairy Sci 2004; 87: 1967-1974.
111. Pan D, Luo Y, Tanokura M. Antihypertensive peptides from skimmed milk hydrolysate digested by cell-free extract of Lactobacillus helveticus JCM1004. Food Chem 2005; 91: 123-129 (Pubitemid 39572541)
112. Ichimura T, Hu J, Aita DQ, Maruyama S. Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce. J Biosci Bioeng 2003; 96: 496-499 (Pubitemid 37533395)
113. Je JY, Park PJ, Byun HG, Jung WK, Kim SK. Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis. Bioresour Technol 2005; 96: 1624-1629 (Pubitemid 40840711)
114. Je JY, Park JY, Jung WK, Park PJ, Kim SK. Isolation of angiotensin I converting enzyme (ACE) inhibitor from fermented oyster sauce, Crossostrea gigas. Food Chem 2005; 90: 809-814
115. Jung WK, Mendis E, Je JY, Park PJ, Son BW, Kim HC, et al. Angiotensin I converting enzyme inhibitory peptides from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats. Food Chem 2006; 94: 26-32. (Pubitemid 40922878)
116. Suetsuna K, Maekawa K, Chen JR. Antihypertensive effects of Undaria pinnatifida (wakame) peptide on blood pressure in spontaneously hypertensive rats. J Nutr Biochem 2004; 15: 267-272 (Pubitemid 38595476)
117. Ferrari CK, Torres EA. Biochemical pharmacology of functional foods and prevention of chronic diseases of aging. Biomed Pharmacother 2003; 57: 251-260
118. Arai S, Osawa T, Ohigashi H, Yoshikawa M, Kaminogawa S, Watanabe M, et al. A mainstay of functional food science in Japan-history, present status, and future outlook. Biosci Biotechnol Biochem 2001; 65: 1-13. (Pubitemid 33617434)
119. Shimizu M. Food-derived peptides and intestinal functions. Biofactors 2004; 21: 43-47
120. Yoshikawa M, Fujita H, Matoba N, Takenaka Y, Yamamoto T, Yamauchi R, et al. Bioactive peptides derived from food proteins preventing lifestyle-related diseases. Biofactors 2000; 12: 143-146 (Pubitemid 32107398)
121. Roberts PR, Burney JD, Black KW, Zaloga GP. Effect of chain length on absorption of biologically active peptides from the gastrointestinal tract. Digestion 1999; 60: 332-337
122. Matsufuji H, Matsui T, Seki E, Osajima K, Nakashima M, Osajima Y. Angiotensin I-converting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle. Biosci Biotechnol Biochem 1994; 58: 2244-2245
123. Gardner ML. Gastrointestinal absorption of intact proteins. Annu Rev Nutr 1988; 8: 329-350
124. Webb KE, Jr. Intestinal absorption of protein hydrolysis products: a review. J Anim Sci 1990; 68: 3011-3022
125. Vermeirssen V, Augustijns P, Morel NJ. Van Camp, Opsomer A, Verstraete W. In vitro intestinal transport and antihypertensive activity of ACE inhibitory pea and whey digests. Int J Food Sci Nutr 2005; 56: 415-430
126. Schmelzer CE, Schops R, Ulbrich-Hofmann R, Neubert RH, Raith K. Mass spectrometric characterization of peptides derived by peptic cleavage of bovine beta-casein. J Chromatogr A 2004; 1055: 87-92. (Pubitemid 39422446)
127. Rival SG, Boeriu CG, Wichers HJ. Caseins and casein hydrolysates. 2. Antioxidative properties and relevance to lipoxygenase inhibition. J Agric Food Chem 2001; 49: 295-302.
128. Rival SG, Fornaroli S, Boeriu CG, Wichers HJ. Caseins and casein hydrolysates. 1. Lipoxygenase inhibitory properties. J Agric Food Chem 2001; 49: 287-294
129. Pentzien AK, Meisel H. Transepithelial transport and stability in blood serum of angiotensin-I-converting enzyme inhibitory dipeptides. Z Naturforsch [C] 2008; 63: 451-459
130. Satake M, Enjoh M, Nakamura Y, Takano T, Kawamura Y, Arai S, et al. Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci Biotechnol Biochem 2002; 66: 378-384 (Pubitemid 39251060)
131. Sato K, Iwai K, Aito-Inoue M. Identification of food-derived bioactive peptides in blood and other biological samples. J AOAC Int 2008; 91: 995-1001.
132. Tsai JS, Chen TJ, Pan BS, Gong SD, Chung MY. Antihypertensive effect of bioactive peptides produced by protease-facilitated lactic acid fermentation of milk. Food Chem 2008; 106: 552-558
133. Pihlanto-Leppa A, Rokka T, Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 1998; 8: 325-331 (Pubitemid 28472225)
134. Van Dyck S, Novakova S, Van Schepdael A, Hoogmartens J. Inhibition study of angiotensin converting enzyme by capillary electrophoresis after enzymatic reaction at capillary inlet. J Chromatogr A 2003; 1013: 149-156 (Pubitemid 37297582)
135. Tsai JS, Lin TC, Chen JL, Pan BS. The inhibitory effects of freshwater clam (Corbicula fluminea, Muller) muscle protein hydrolysates on angiotensin I converting enzyme. Process BioChem 2006; 41: 2276-2281
136. Byun HG, Kim SK. Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin. J Biochem Mol Biol 2002; 35: 239-243 (Pubitemid 34389495)
137. Fujita H, Yoshikawa M. LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 1999; 44: 123-127
138. Pinto YM, Paul M, Ganten D. Lessons from rat models of hypertension: from goldblatt to genetic engineering. Cardiovasc Res 1998; 39: 77-88. (Pubitemid 28322381)
139. Ganapathy V, Leibach FH. Protein digestion and assimilation. Textbook of Gastroenterology 1999; pp. 456-467
140. Ganong WF. Section V. Gastrointestinal function. Rev Med Physiol 1997; pp. 437-481
141. Drescher K, Roos N, Pfeuffer M, Seyfert HM, Schrezenmeir J, Hagemeister H. Recovery of 15N-lactoferrin is higher than that of 15N-casein in the small intestine of suckling, but not adult miniature pigs. J Nutr 1999; 129: 1026-1030 (Pubitemid 129785935)
142. Roos N, Mahe S, Benamouzig R, Sick H, Rautureau J, Tome D. 15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. J Nutr 1995; 125: 1238-1244
143. FitzGerald RJ, Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr 2000; 84 (Suppl 1): S33-7. (Pubitemid 32106827)
144. Vanhoof G, Goossens F, De Meester I, Hendriks D, Scharpe S. Proline motifs in peptides and their biological processing. FASEB J 1995; 9: 736-744
145. Wu J, Ding X. Characterization of inhibition and stability of soy-protein-derived angiotensin I-converting enzyme inhibitory peptides. Food Res Int 2002; 35: 367-375 (Pubitemid 34294400)
146. Meisel H, Frister H. Chemical characterization of bioactive peptides from in vivo digests of casein. J Dairy Res 1989; 56: 343-349
147. Svedberg J, de Haas J, Leimenstoll G, Paul F, Teschemacher H. Demonstration of beta-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides 1985; 6: 825-830
148. Chabance B, Marteau P, Rambaud JC, Migliore-Samour D, Boynard M, Perrotin P, et al. Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 1998; 80: 155-165 (Pubitemid 28185054)
149. Fernandes L, Fortes ZB, Casarini DE, Nigro D, Tostes RC, Santos RA, et al. Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR. Regul Pept 2005; 127: 183-189
150. Deja MA, Golba KS, Widenka K, Mrozek R, Biernat J, Kolowca M, et al. Angiotensin-converting enzyme inhibitors reveal non-NO-, non-prostacycline- mediated endothelium-dependent relaxation in internal thoracic artery of hypertensive patients. Int J Cardiol 2005; 102: 455-460 (Pubitemid 40956906)
151. Guazzi M, Agostoni P. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane. Clin Sci (Lond) 1999; 96: 17-22. (Pubitemid 29045860)
152. Nurminen ML, Sipola M, Kaarto H, Pihlanto-Leppala A, Piilola K, Korpela R, et al. Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci 2000; 66: 1535-1543 (Pubitemid 30155383)
153. Gómez-Ruiz J, Ramos M, Recio I. Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion. Int Dairy J 2004; 14: 1075-1080
154. Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotechnol Biochem 1994; 58: 1767-1771
155. Sekiya S, Kobayashi Y, Kita E, Imamura Y, Toyama S. Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. J Japanese Society Nutritional Food Sci 1992; 45: 513-517
156. Agostoni A, Cicardi M, Cugno M, Zingale LC, Gioffre D, Nussberger J. Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology 1999; 44: 21-25
157. Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors. Circulation 1998; 97: 1411-1420
158. Johnston CI, Risvanis J. Preclinical pharmacology of angiotensin II receptor antagonists: update and outstanding issues. Am J Hypertens 1997; 10: 306S-10. (Pubitemid 28133254)
159. Nielsen CU, Brodin B. Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and pathophysiological conditions. Curr Drug Targets 2003; 4: 373-388 (Pubitemid 36758317)
160. Brandsch M, Knutter I, Leibach FH. The intestinal H+/peptide symporter PEPT1: structure-affinity relationships. Eur J Pharm Sci, 2004; 21: 53-60. (Pubitemid 38050203)
161. Terada T, Inui K. Peptide transporters: structure, function, regulation and application for drug delivery. Curr Drug Metab 2004; 5: 85-94. (Pubitemid 38292002)
162. Biegel A, Knutter I, Hartrodt B, Gebauer S, Theis S, Luckner P, et al. The renal type H+/peptide symporter PEPT2: structure-affinity relationships. Amino Acids 2006; 31: 137-156 (Pubitemid 44222575)
163. Daniel H, Kottra G. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Archiv Eur J Physiol 2004; 447: 610-618 (Pubitemid 38241445)
164. Webb Jr, K.E. Intestinal absorption of protein hydrolysis products: a review. J Anim Sci 1990; 68: 3011-3022
165. Grimble GK. Mechanisms of peptide and amino acid transport and their regulation. Nestle Nutr Workshop Ser Clin Perform Programme 2000; 3: 63-84; discussion 84-168
166. Ziv E, Bendayan M. Intestinal absorption of peptides through the enterocytes. Microsc Res Tech 2000; 49: 346-352 (Pubitemid 30407770)
167. Gardner ML. Intestinal assimilation of intact peptides and proteins from the diet - a neglected field? Biol Rev Camb Philos Soc 1984; 59: 289-331.
168. Walker WA. Absorption of protein and protein fragments in the developing intestine: Role in immunologic/allergic reactions. Pediatrics 1985; 75: S167-71.
169. Morris MC, Deshayes S, Heitz F, Divita G. Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol Cell 2008; 100: 201-217
170. Morris MC, Depollier J, Mery J, Heitz F, Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 2001; 19: 1173-1176 (Pubitemid 33115705)
171. Brayden DJ, O'Mahony DJ. Novel oral drug delivery gateways for biotechnology products: Polypeptides and vaccines. Pharmaceut Sci Technol Today 1998; 1: 291-299
172. Hasler C.M. The changing face of functional foods. J Am Coll Nutr, 2000; 19 Suppl: 499S-506.
173. Roberfroid MB. A European consensus of scientific concepts of functional foods. Nutrition 2000; 16: 689-691 (Pubitemid 30445152)
174. AA.VV. Global Market Review of Functional Foods - Forecasts to 2010. 2004, Rockville, MD US: MarketResearch.com.
175. Murray BA, FitzGerald RJ. Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Curr Pharm Des 2007; 13: 773-791
176. Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 1996; 126: 3063-3068 (Pubitemid 27023881)
177. Flambard B. Composition with heart rate reducing properties. European patent application. EP1466529 2004.
178. Flambard B. Peptides with anti-hypertensive properties. United states patent and trademark office pre-grant publication 2005.
179. Hernandez-Ledesma B, Miralles B, Amigo L, Ramos M, Recio I. Identification of antioxidant and ACE-inhibitory peptides in fermented milk. J Sci Food Agric 2005; 85: 1041-1048 (Pubitemid 40534391)
180. Lehrer SB, Bannon GA. Risks of allergic reactions to biotech proteins in foods: perception and reality. Allergy 2005; 60: 559-564
181. Arai S. Global view on functional foods: Asian perspectives. Br J Nutr 2002; 88 (Suppl): S139-43. (Pubitemid 35363339)
182. Halsted CH. Dietary supplements and functional foods: 2 sides of a coin? Am J Clin Nutr 2003; 77 (Suppl): 1001S-7S.
183. Coppens P, da Silva MF, Pettman S. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety. Toxicology 2006; 221: 59-74. (Pubitemid 43325007)
184. Kumar S, Dudley J. Bioinformatics software for biologists in the genomics era. Bioinformatics 2007; 23: 1713-1717 (Pubitemid 47250302)
185. Perez-Iratxeta C, Andrade-Navarro MA, Wren JD. Evolving research trends in bioinformatics. Brief Bioinform 2007; 8: 88-95.
186. Pripp AH, Isaksson T, Stepaniak L, Sørhaug T. Quantitative structure-activity relationship modelling of ACE-inhibitory peptides derived from milk proteins. Eur Food Res Technol 2004; 219: 579-583 (Pubitemid 39633390)
187. Pripp AH, Isaksson T, Stepaniak L, Sørhaug T, Ardo Y. Quantitative structure activity relationship modelling of peptides and proteins as a tool in food science. Trends Food Sci Technol 2005; 16: 484-494 (Pubitemid 41528783)
188. Pripp AH. Quantitative structure-activity relationship of prolyl oligopeptidase inhibitory peptides derived from beta-casein using simple amino acid descriptors. J Agric Food Chem 2006; 54: 224-228
189. Fernandez M, Caballero J. Analysis of protegrin structure-activity relationships: The structural characteristics important for antimicrobial activity using smoothed amino acid sequence descriptors. Mol Simulation 2007; 33: 689-702. (Pubitemid 47301164)
190. Kim HO, Li-Chan EC. Quantitative structure-activity relationship study of bitter peptides. J Agric Food Chem 2006; 54: 10102-10111 (Pubitemid 46159016)
191. Wu J, Aluko RE. Quantitative structure-activity relationship study of bitter di- and tri-peptides including relationship with angiotensin I-converting enzyme inhibitory activity. J Pept Sci 2007; 13: 63-69 (Pubitemid 46190035)
192. Pripp AH, Ardo Y. Modelling relationship between angiotensin-(I)- converting enzyme inhibition and the bitter taste of peptides. Food Chem 2007; 102: 880-888
193. Pripp AH. Docking and virtual screening of ACE inhibitory dipeptides. European Food Res Technol 2007; 225: 589-592 (Pubitemid 46945678)
194. Tarca AL, Carey VJ, Chen XW, Romero R, Draghici S. Machine learning and its applications to biology. PLoS Comput Biol 2007; 3: 116.
195. Saito T. Antihypertensive peptides derived from bovine casein and whey proteins. Adv Exp Med Biol 2008; 606: 295-317.
196. Saito T, Nakamura T, Kitazawa H, Kawai Y, Itoh T. Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. J Dairy Sci 2000; 83: 1434-1440
197. De Leo F, Gallerani R, Losacco M, Gobbetti M, Minervini F. Biopeptides with anti-hypertensive activity from bovine beta-casein. Patent cooperation treaty application. WO2007017160 2007.
198. Pihlanto-Leppa A. Bioactive peptides derived from bovine whey proteins: Opioid and ace-inhibitory peptides. Trends Food Sci Technol 2000; 11: 347-356 (Pubitemid 32516037)
199. Loponen J. Angiotensin converting enzyme inhibitory peptides in Finnish cereals: a database survey. Agric Food Sci 2004; 13: 39-45. (Pubitemid 38927854)
200. Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I-converting enzyme inhibition from wheat germ. J Pept Sci 1999; 5: 289-297 (Pubitemid 29358508)
201. Byun HG, Kim SK. Purification and characterization of angiotensin I converting enzyme (ACE) inhibitory peptides from Alaska pollack (Theragra chalcogramma) skin. Process BioChem 2001; 36: 1155-1162
202. Kim SK, Byun HG, Park PJ, Shahidi F. Angiotensin I converting enzyme inhibitory peptides purified from bovine skin gelatin hydrolysate. J Agric Food Chem 2001; 49: 2992-2997
203. Shin ZI, Yu R, Park SA, Chung DK, Ahn CW, Nam HS, et al. His-His-Leu, an angiotensin I converting enzyme inhibitory peptide derived from Korean soybean paste, exerts antihypertensive activity in vivo. J Agric Food Chem 2001; 49: 3004-3009
204. Matsumura N, Fujii M, Takeda Y, Sugita K, Shimizu T. Angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci Biotechnol Biochem 1993; 57: 695-697
205. Li CH, Matsui T, Matsumoto K, Yamasaki R, Kawasaki T. Latent production of angiotensin I-converting enzyme inhibitors from buckwheat protein. J Pept Sci 2002; 8: 267-274 (Pubitemid 34649814)
206. Ariyoshi Y. Angiotensin-converting enzyme inhibitors derived from food proteins. Trends Food Sci Technol 1993; 4: 139-144
207. Nakagawa Y, Kitamura S. Processes for producing milk-derived alcoholic beverages, in european patent application EP032383 1989.
208. Draaisma R, Bernardus M, Koning Maria, G, Ledeboer A, Marinus, Schalk J. Fermented Milk Product Comprising Tripeptide Vpp And/Or Ipp. Patent Cooperation Treaty Application WO2004060073 2004.
209. Tossavainen O, Suomalainen T, Sahlstein J, Mäyrä-Mäkinen A. Process for producing a product containing antihypertensive tripeptides. United States Patent And Trademark Office Granted Patent US6972282 2005.
210. Davis ME, Rao A, Gauthier S, Pouliot Y, Gourley L, Allain AF. Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products. United States Patent And Trademark Office Granted Patent US6998259 2006.
211. Fujita H, Yasumoto R, Hasegawa M. Granular Soup Containing Peptide. Patent Abstracts Of Japan JP11225715 1999.
212. Sugai R, Murakami U, Yamori Y. Preventive For Circulatory Diseases. Patent Cooperation Treaty Application JP62270533 1995.
213. Janssen J, Gerardus, Maria and J. Schalk. Peptides Having An Ace Inhibiting Effect. Patent Cooperation Treaty Application WO2004098310 2004.
214. Edens L, Roos D, Leonardus A, Hoeven VD, Robertus Antonius Mijndert, Deen PA. Blood Pressure Lowering Oligopeptides. Patent Cooperation Treaty Application WO2006005757 2006.
215. Bree A, De And C. Gerhardt, Christina. Composition Comprising Peptide. Patent Cooperation Treaty Application WO2006084560 2006.
216. Cadee J, Adriana and L. Mallee, Franciscus. Peptides Inhibiting Angiotensin-Converting Enzyme. Patent Cooperation Treaty Application WO2007004876 2007.
217. Flambard B. Peptides With Anti-Hypertensive Properties. Patent Cooperation Treaty Application WO03082019 2003.
218. Flambard B. Process For Preparing Peptides With Anti-Hypertensive Properties. Patent Cooperation Treaty Application WO2004015125 2004.
219. Flambard B. Isolated Dipeptides With Ace Inhibitor Effect. Patent Cooperation Treaty Application WO2006125441 2006.
220. Kristiansen B. Bioactive Agents Produced By Submerged Cultivation Of A Basidiomycete Cell. Patent Cooperation Treaty Application WO2006133708 2006.
221. Kubow S, Sheppard J. Use Of Soy Kefir Powder For Reducing Pain, Blood Pressure And Inflammation. Patent Cooperation Treaty Application WO2007087722 2007.
222. Manzanares Mir, P.M., J.F. Marcos Lopez, M. Enrique López, S. Valles Alventosa, J.M. Centeno Guil, J.B. Salom Sanvalero, G. Torregrosa Bernabe, E. Alborch Dominguez. Dairy-Protein-Derived Peptides With Angiotensin 1 Converting Enzyme Inhibitory Activity. Patent Cooperation Treaty Application WO2007113365 2007.
223. Miguel Castro M, Inst. Fermentaciones Ind., R. Lopez-Alonso Fandiño, Inst. Fermentaciones Ind., M.I. Recio Sanchez, Inst. Fermentaciones Ind., M.M. Ramos Gonzales, Inst. Fermentaciones Ind., A. Aleixandre De Artiñano, Inst. Farma. Y Toxic., Bioactive Peptides Derived From The Proteins Of Egg White By Means Of Enzymatic Hydrolysis. European Patent EP1661913 2006.
224. Muguerza Marquinez, B., M.A. Delgado Delgado, A. Quiros Del Bosque, I. Recio Sanchez, M. Ramos Gonzalez, M. Aleixandre De Artinano, Amaya, Bioactive Peptide-Producing Strains Of I Enterococcus Faecalis /I , Bioactive Peptides And Applications Thereof. European Patent Application EP1640447 2006.
225. Perez-Garcia, M.E.D.L., C.R. Diniz, R. Dos Santos, Augusto, Souza, P. Bougis, Edouard, M.-F. Euclair, and A.M.D.C.P. Pimenta. Scorpion Peptide as Hypotensive Agent. Patent Cooperation Treaty Application WO03104274 2003.
226. Recio Sanchez, I., Insto De Fermentaciones Ind, A. Quiros Del Bosque, Insto De Fermentaciones In, B. Hernandez Ledesma, Insto De Fermentaciones, J.A. Gomez Ruiz, Insto De Fermentaciones In, M. Miguel Castro, Insto De Fermentaciones Ind., M.L. Amigo Garrido, Insto De Fermentacio, I. Lopez Exposito, Insto De Fermentaciones Ind., M.M. Ramos Gonzalez, Insto De Fermentaciones, A. Aleixandre De Artiñano, Ins Farma. Y Toxicolog, And M. Contreras Gómez, Insto De Fermentaciones Ind., Bioactive Peptides Identified In Enzymatic Hydrolyzates Of Milk Caseins and Method of obtaining same. European Patent Application EP1905779 2008.
227. Van Der Burg-Koorevaar, M.C., R.B. Draaisma, J. Schalk, Hydrolysed Casein Product Comprising Tripeptides Ipp And/Or Vpp. United States Patent And Trademark Office Pre-Grant Publication WO2004098309 2007.
228. Wu, JP., A.D. Muir, R.E. Aluko, Ace Inhibitory Peptides From Plant Materials. United States Patent And Trademark Office Pre-Grant Publication WO2004057976 2006.
229. Jankowski P, Safar ME, Benetos A. Pleiotropic effects of drugs inhibiting the renin-angiotensin-aldosterone system. Curr Pharm Des 2009; 15(5): 571-584
230. Protogerou AD, Stergiou GS, Vlachopoulos C, Blacher J, Achimastos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: Evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr Pharm Des 2009; 15(3): 272-289
231. Shindel AW, Kishore S, Lue TF. Drugs designed to improve endothelial function: effects on erectile dysfunction. Curr Pharm Des 2008; 14(35): 3758-3767